期刊文献+

某县医院基于临床路径的两个单病种住院费用控制分析 被引量:8

Two Single Sort Disease Costs Control Analysis of Inpatients Based on the Clinical Pathway in A County Hospital
暂未订购
导出
摘要 目的选择实施临床路径管理的某县医院,选取剖宫产和高血压Ⅲ级两个病种,探讨不同支付方式(单病种和按项目付费)对住院总费用的影响。方法采用定量分析的方法比较单病种和按项目付费的住院病人年龄分布、住院时间和住院费用等,以及住院费用和住院病人年龄、住院时间和药占比的相关性。结果剖宫产单病种付费组的西药费、诊疗费、护理费、手术费和化验费低于按项目付费组,中成药费和其他费用高于按项目付费组(P<0.05);高血压Ⅲ级单病种付费组的中成药费、化验费和其它费用均低于按项目付费组(P<0.05)。两个病种的总住院费用单病种付费均低于按项目付费组,且总住院费用均与住院时间呈正相关(P<0.05)。结论剖宫产和高血压Ⅲ级两类病种采用单病种付费方式,与传统的按项目付费比较,能较好地控制住院费用的不合理增长,基本达到了控费的目的。 Objective To choose cesarean birth and stage Ⅲ the clinical path management and to explore effect of different hypertension disease of a county hospital with payment methods (single sort disease and pay by project) on the total cost of hospitalization. Methods Age distribution, length of stay and hospital costs were compared between inpatients with the single disease and fee -for -patient as well as the correlation of age and inpatient hospital costs, length of stay and the proportion of the drug were analyzed by using quantitative analysis method. Results Medicine costs , treatment fees, care fees, surgery and laboratory fees of cesarean patients paid by single sort disease were significantly lower than those in patients paid by project while Chinese medicine and other fees of cesarean single sort disease group were significantly higher than those in patients paid by project ( P 〈 0.05 ). Chinese medicine fee, laboratory fees and other costs of hypertension Ill patients paid by single sort disease were lower significantly than those patients paid by project ( P 〈 0.05 ). The total cost of patients paid by single sort disease were lower than those in patients paid by project (P 〈 0. 05). Conclusion Compared with the traditional cost paid method, single sort disease cost paid method could control the unreasonable growth in hospital costs.
机构地区 宁夏医科大学
出处 《宁夏医科大学学报》 2014年第1期59-61,共3页 Journal of Ningxia Medical University
关键词 单病种付费 按项目付费 费用控制 single sort disease cost pay by project cost control
  • 相关文献

参考文献6

二级参考文献22

  • 1周宇,郑树忠,孙国桢.德国DRG付费制度的借鉴[J].中国卫生资源,2004,7(4):186-187. 被引量:31
  • 2马骏.临床路径备要[J].中国卫生质量管理,2005,12(1):1-3. 被引量:32
  • 3周苏平.对单病种限价收费利弊的思考[J].现代医药卫生,2006,22(24):3844-3845. 被引量:6
  • 4Thomss R,Gadacz MD.Geneeeral surgical clinical pathways:an introduction[J].The American Surgeon,1997,63(1):107-110.
  • 5高建民.陕西省医疗服务成本测算与价格政策研究[C].西安交通大学人文社科论文集,2002.12.
  • 6陕西省物价局,陕西省卫生厅.陕西省医疗服务项目价格[S].2002.5.
  • 7CRMMER M B,CARTER V.Clinical pathw-the pavotal too[J].Cariovase-Nurs,1993,7(4):30-34.
  • 8尹爱田 钱东福.按病种付费方案的“费用控制”策略.医院领导决策参考,2006,(2):34-39.
  • 9汪沿安.美国DRGs付费模式的中国启示.医院领导决策参考,2006,(22):46-49.
  • 10Fetter RB,刘翠娥.按诊断分类定额付款医疗收费制度的制定[J]国外医学(卫生经济分册),1988(02).

共引文献58

同被引文献49

  • 1Qiu M, Shen W, Song X, et al. Effects ofprediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellims: longitudinal study [J]. Hypertension, 2015, 65 (3): 525-530.
  • 2Zhang C, Chow FC, Hart Y, et al. Multieenter cohort study of diabetes mallitus and impaired fasting glucose in HIV.infected patients in Chi- na[J]. J Acquir Immune Doric Syndr, 2015, 68(3): 298-303.
  • 3Kobayashi K, Nakashima N, Inoguchi T, etal. Disease managcraent for diabetes mellitus to prevent the onset and progression of compli- cations[J]. Rinsho Byori, 2012, 60(11): 1101-1106.
  • 4Porteons GH, Neal JM, Slee A, etal. A standardized anesthetic and surgical clinical pathway for esophageal resection:impact on length of stay and major outcomes [J]. Reg Anesth Pain Med, 2015, 40(2): 139-149.
  • 5Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: under- standing the route to clinical efficacy[J]. Nat Rev Drug Discov, 2014, 13(3): 217-236.
  • 6Waanders F, Visser FW, Gans RO. Current concepts in the manage- ment of diabetic nephropathy[J]. Neth J Meal, 2013, 71(9): 448-458.
  • 7Taneera J, Storm P, Groop L. Downregulation of type II diabetes mel- litus and maturity onset diabetes of young pathways In human pancre- atic islets fi'om hyperglycemic donors[J]. J Diabetes Res, 2014, 2014: 237535.
  • 8Lima MH, Caricllli AM, De Abreu LL, et al. Topical insulin acceler- ates wound healing in diabetes by enhancing the AKT and ERK path- ways: a donhle-blind placebo-controlled clinical trial [J]. PLoS One, 2012, 7(5): e36974.
  • 9Seroussi B, Falcoff H, Ertel-Pau V, et al. Online dissemination of clinical practice guidelines as narrative texts and structured pathways: a case study with the treatment of type 2 diabetes [J]. Stud Health Technol Inform, 2014, 205:28-32.
  • 10Matsumoto K. Clinical usefulness of educational admission in dia- betes mellitus[J]. Nihon Rinsho, 2012, 5:628-632.

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部